These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12432216)

  • 21. An isozyme of hexokinase specific for the human red blood cell (HKR).
    Murakami K; Blei F; Tilton W; Seaman C; Piomelli S
    Blood; 1990 Feb; 75(3):770-5. PubMed ID: 2297576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isozymes of plant hexokinase: occurrence, properties and functions.
    Claeyssen E; Rivoal J
    Phytochemistry; 2007 Mar; 68(6):709-31. PubMed ID: 17234224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic and regulatory properties of HK I(+), a modified form of the type I isozyme of mammalian hexokinase in which interactions between the N- and C-terminal halves have been disrupted.
    Hashimoto M; Wilson JE
    Arch Biochem Biophys; 2002 Mar; 399(1):109-15. PubMed ID: 11883910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of the gene for type I hexokinase from rat.
    White JA; Wilson JE
    Arch Biochem Biophys; 1997 Jul; 343(2):207-14. PubMed ID: 9224732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testis-specific expression of mRNAs for a unique human type 1 hexokinase lacking the porin-binding domain.
    Mori C; Nakamura N; Welch JE; Shiota K; Eddy EM
    Mol Reprod Dev; 1996 May; 44(1):14-22. PubMed ID: 8722688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rare genetically determined electrophoretic variant of human leucocyte type III hexokinase.
    Katzen HM; Soderman DD
    Arch Biochem Biophys; 1988 May; 262(2):626-35. PubMed ID: 3364986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular bases of hexokinase deficiency.
    Bianchi M; Crinelli R; Serafini G; Giammarini C; Magnani M
    Biochim Biophys Acta; 1997 May; 1360(3):211-21. PubMed ID: 9197463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biallelic hexokinase 1 (HK1) variants causative of non-spherocytic haemolytic anaemia: A case series with emphasis on the HK1 promoter variant and literature review.
    Ukonmaanaho EM; Dell'Anna S; Hakonen A; Wartiovaara-Kautto U; Kakko S; Rab MAE; van Oirschot B; Kraatari-Tiri M; van Wijk R; Rahikkala E
    Br J Haematol; 2024 May; 204(5):2040-2048. PubMed ID: 38415930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hexokinase type II: a novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells.
    Katabi MM; Chan HL; Karp SE; Batist G
    Hum Gene Ther; 1999 Jan; 10(2):155-64. PubMed ID: 10022541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of gene dosage effect for HK 1 in the red cells of a patient with trisomy 10pter leads to p13.
    Dallapiccola B; Serena Lungarotti M; Magnani M; Dacha M
    Ann Genet; 1981; 24(1):45-7. PubMed ID: 6971618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase.
    Shoshan-Barmatz V; Zakar M; Rosenthal K; Abu-Hamad S
    Biochim Biophys Acta; 2009 May; 1787(5):421-30. PubMed ID: 19094960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homophilic anchorage of brain-hexokinase to mitochondria-porins revealed by specific-peptide antibody cross recognition.
    Oudard S; Miccoli L; Beurdeley-Thomas A; Dutrillaux B; Poupon MF
    Bull Cancer; 2004 Jun; 91(6):E184-200. PubMed ID: 15562563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hexokinase deficiency in hemolytic anemia].
    Moser K; Ciresa M; Schwarzmeier J
    Med Welt; 1970 Nov; 46():1977-81. PubMed ID: 5512853
    [No Abstract]   [Full Text] [Related]  

  • 34. Expression of hexokinase 1 and hexokinase 2 in mammary tissue of nonlactating and lactating rats: evaluation by RT-PCR.
    Kaselonis GL; McCabe ER; Gray SM
    Mol Genet Metab; 1999 Nov; 68(3):371-4. PubMed ID: 10562464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two Sp sites are important cis elements regulating the upstream promoter region of the gene for rat type I hexokinase.
    Liu W; Wilson JE
    Arch Biochem Biophys; 1997 Oct; 346(1):142-50. PubMed ID: 9328294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human uroporphyrinogen-III synthase: genomic organization, alternative promoters, and erythroid-specific expression.
    Aizencang G; Solis C; Bishop DF; Warner C; Desnick RJ
    Genomics; 2000 Dec; 70(2):223-31. PubMed ID: 11112350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional organization and evolution of mammalian hexokinases: mutations that caused the loss of catalytic activity in N-terminal halves of type I and type III isozymes.
    Tsai HJ
    Arch Biochem Biophys; 1999 Sep; 369(1):149-56. PubMed ID: 10462451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete genomic organization of the human erythroid p55 gene (MPP1), a membrane-associated guanylate kinase homologue.
    Kim AC; Metzenberg AB; Sahr KE; Marfatia SM; Chishti AH
    Genomics; 1996 Jan; 31(2):223-9. PubMed ID: 8824805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional organization of mammalian hexokinases: both N- and C-terminal halves of the rat type II isozyme possess catalytic sites.
    Tsai HJ; Wilson JE
    Arch Biochem Biophys; 1996 May; 329(1):17-23. PubMed ID: 8619630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some drug effects on the activity of erythrocyte hexokinase and glucose 6-phosphate dehydrogenase enzymes in vitro and in vivo.
    Ciftçi M; Senyayla F; Ozdemir H; Büyükokuroğlu ME
    Pol J Pharmacol; 2002; 54(6):673-9. PubMed ID: 12866723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.